等待开盘 06-25 09:30:00 美东时间
-0.050
-1.10%
The latest update is out from LifeMD ( ($LFMD) ). On June 22, 2026, LifeMD anno...
06-22 21:19
LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, the only FDA-approved once-weekly subcutaneous testostero...
06-22 20:10
LifeMD files Form 3 for CTO Sripad Umesh, reports no beneficial ownership holdings LifeMD filed an initial beneficial ownership statement naming Sripad Umesh as chief technology officer, dated June 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artifi
06-04 08:52
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.
05-27 00:36
LifeMD, Inc. announced that its management will participate in two upcoming investor conferences: the LD Micro Invitational XVI in Los Angeles on May 17-19, 2026, and the B. Riley Securities 26th Annual Investor Conference in Marina del Rey on May 20-21, 2026. LifeMD is a leading virtual primary care platform offering telemedicine, lab, and pharmacy services across 200 conditions.
05-15 12:00
LifeMD shares are trading lower. The company reported its Q2 financial results.
05-07 05:11
Gainers Agilon Health (NYSE:AGL) stock increased by 22.1% to $34.0 during Wedn...
05-07 05:03
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40